32 related articles for article (PubMed ID: 19058876)
1. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review.
Brouwer ED; Watkins D; Olson Z; Goett J; Nugent R; Levin C
BMC Public Health; 2015 Nov; 15():1183. PubMed ID: 26612044
[TBL] [Abstract][Full Text] [Related]
2. A review of health system infection control measures in developing countries: what can be learned to reduce maternal mortality.
Hussein J; Mavalankar DV; Sharma S; D'Ambruoso L
Global Health; 2011 May; 7():14. PubMed ID: 21595872
[TBL] [Abstract][Full Text] [Related]
3. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
4. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
5. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
6. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery.
Gillespie EL; White CM; Kluger J; Rancourt JA; Gallagher R; Coleman CI
Pharmacotherapy; 2006 Apr; 26(4):499-504. PubMed ID: 16553508
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
9. Problems and solutions in hospital-acquired bacteraemia.
Correa L; Pittet D
J Hosp Infect; 2000 Oct; 46(2):89-95. PubMed ID: 11049700
[TBL] [Abstract][Full Text] [Related]
10. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
11. [Hospital-acquired bacteraemia and fungaemia. A regional study with national implications].
Schønheyder HC; Søgaard M
Ugeskr Laeger; 2007 Nov; 169(48):4175-9. PubMed ID: 18211787
[TBL] [Abstract][Full Text] [Related]
12. The impact of nosocomial infections on hospital care costs.
Lauria FN; Angeletti C
Infection; 2003 Dec; 31 Suppl 2():35-43. PubMed ID: 15018471
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
